Latest market price
48.44
+0.77+1.62%
TA
Loading chart...
Snapshot
| Index | — | P/E | 21.72 | EPS (ttm) | 2.23 | Insider Own | 11.44% | Shs Outstand | 307.15M | Perf Week | 2.30% |
| Market Cap | 14.88B | Forward P/E | 15.73 | EPS next Y | 3.08 | Insider Trans | 0.00% | Shs Float | 306.49M | Perf Month | 15.94% |
| Enterprise Value | 17.61B | PEG | 1.89 | EPS next Q | 0.12 | Short Float | 3.72% | Perf Quarter | 14.49% | ||
| Income | 717.00M | P/S | 3.93 | EPS this Y | 22.25% | Short Ratio | 7.38 | Perf Half Y | 1.06% | ||
| Sales | 3.79B | P/B | 7.09 | EPS next Y | 13.26% | ROA | 7.88% | Short Interest | 11.41M | Perf YTD | 2.95% |
| Book/sh | 6.83 | P/C | 6.43 | EPS next 5Y | 11.51% | ROE | 40.36% | 52W High | 56.64 -14.48% | Perf Year | 25.01% |
| Cash/sh | 7.54 | P/FCF | 13.14 | EPS past 3/5Y | — | ROIC | 9.41% | 52W Low | 38.06 27.27% | Perf 3Y | 31.31% |
| Dividend Est. | 1.74 (3.59%) | EV/EBITDA | 13.82 | Sales past 3/5Y | 18.49% 18.32% | Gross Margin | 42.13% | Volatility | 2.89% 2.56% | Perf 5Y | 2.89% |
| Dividend TTM | 2.17 (4.48%) | EV/Sales | 4.65 | EPS Y/Y TTM | 36.97% | Oper. Margin | 27.96% | ATR (14) | 1.32 | Perf 10Y | 324.91% |
| Dividend Ex-Date | Sep 08, 2026 | Quick Ratio | 1.20 | Sales Y/Y TTM | 12.47% | Profit Margin | 18.93% | RSI (14) | 65.79 | Recom | 2.58 |
| Dividend Gr. 3/5Y | 103.89% 39.25% | Current Ratio | 1.21 | EPS Q/Q | 32.20% | SMA20 | 6.52% | Beta | 0.08 | Target Price | 54.00 |
| Payout | 92.13% | Debt/Eq | 2.41 | Sales Q/Q | 17.66% | SMA50 | 7.95% | Rel Volume | 0.99 | Prev Close | 47.67 |
| Employees | 26,458 | LT Debt/Eq | 2.09 | Earnings | Nov 16 | SMA200 | 3.14% | Avg Volume | 1.55M | Price | 48.44 |
| IPO Date | Mar 26, 2010 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 3.93% 5.21% | Net Debt/EBITDA | 2.14 | Volume | 1,543,397 | Change | 1.62% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Mar-09-26 | Upgrade | UBS | Neutral → Buy | $62 |
| Feb-04-25 | Reiterated | HSBC | Buy | $54 → $32 |
| Sep-27-24 | Reiterated | Citigroup | Neutral | $54 |
| May-24-24 | Reiterated | Morgan Stanley | Equal Weight | $56 |
| May-21-24 | Reiterated | HSBC | Buy | $52 → $54 |
| Apr-19-24 | Initiated | Macquarie | Outperform | $48 |
| Mar-22-24 | Reiterated | HSBC | Buy | $47 → $52 |
| Aug-31-22 | Reiterated | HSBC | Buy | $47 |
| Dec-08-20 | Downgrade | Credit Suisse | Outperform → Neutral | |
| Aug-24-20 | Upgrade | B of A Securities | Neutral → Buy |
Latest News· Times ET
Oct-29-26
Oct-28-26
Oct-28-2611:32AM
Oct-26-26
Oct-26-2604:57AM
Oct-18-26
Oct-10-26
Sep-24-26
Sep-16-26
Sep-16-2606:15AM
Sep-14-26
Sep-14-2601:45PM
09:40AM
Sep-09-26
Sep-09-2607:15PM
Sep-03-26
08:15PM
Sep-02-26
Sep-02-2610:55AM
Aug-24-26
Company
H World Group Limited, through its various subsidiaries, is actively engaged in the development and management of hotels primarily within the People's Republic of China. Its extensive operations cover a range of models, including leased, owned, manachised, and franchised properties. The company boasts a diverse collection of self-owned hotel brands, among them HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, Ibis Hotel, JI Hotel, Orange Hotel, Starway Hotel, Ibis Styles Hotel, CitiGO Hotel, Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, MAXX by Steigenberger, Jaz in the City, Grand Mercure, Steigenberger Icon, and Song Hotels. As of June 30, 2022, the group oversaw 8,176 hotels, providing a combined total of 773,898 rooms. Originally known as Huazhu Group Limited, the company officially rebranded to H World Group Limited in June 2022. Founded in 2005, its corporate headquarters are situated in Shanghai, People's Republic of China.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,788 | 3,427 | 3,320 | 3,090 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 2,239 | 2,077 | 1,950 | 2,025 | — | — | — | — | — | |
| Gross Profit | 1,549 | 1,350 | 1,370 | 1,065 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 527 | 492 | 512 | 450 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | -38 | -14 | 136 | -51 | — | — | — | — | — | |
| Operating Income | 1,061 | 872 | 723 | 666 | — | — | — | — | — | |
| Interest Expense | 44 | 46 | 44 | 54 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 41 | 159 | -16 | 142 | — | — | — | — | — | |
| Net Income Before Taxes | 1,057 | 985 | 662 | 753 | — | — | — | — | — | |
| Income Taxes | 340 | 293 | 231 | 170 | — | — | — | — | — | |
| Consolidated Net Income | 717 | 688 | 424 | 577 | — | — | — | — | — | |
| Net Income From Continuing Operations | 718 | 693 | 431 | 583 | — | — | — | — | — | |
| Net Income | 717 | 688 | 424 | 577 | — | — | — | — | — | |
| EPS (Recurring) | 2.32 | 2.24 | 1.36 | 1.81 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 2.32 | 2.24 | 1.36 | 1.81 | — | — | — | — | — | |
| EPS (Diluted) | 2.23 | 2.12 | 1.33 | 1.77 | — | — | — | — | — | |
| EBITDA | 1,274 | 1,206 | 897 | 1,009 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 21.72 | 22.23 | 24.76 | 18.94 | — | — | — | — | — | |
| Price To Sales Ratio | 4.03 | 4.21 | 3.10 | 3.53 | — | — | — | — | — | |
| Gross Margin | 40.89 | 39.39 | 41.27 | 34.47 | — | — | — | — | — | |
| Operating Margin | 28.01 | 25.44 | 21.78 | 21.55 | — | — | — | — | — | |
| Net Margin | 18.93 | 20.08 | 12.77 | 18.67 | — | — | — | — | — | |
| Shares Outstanding | 315 | 307 | 312 | 326 | — | — | — | — | — | |
| Market Capitalization | 15,259 | 14,444 | 10,305 | 10,901 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Jin Hui | Chief Executive Officer | Sep 26 '26 | Option Exercise | 0.00 | 107,660 | 0 | 7,129,310 | Sep 29 |
| Leverenz Justin Martin | Director | Aug 15 '26 | Option Exercise | 0.00 | 164,050 | 0 | 164,050 | Aug 18 |
| Zhang Yi | Director | Aug 15 '26 | Option Exercise | 0.00 | 65,620 | 0 | 65,620 | Aug 18 |
| WU JOHN JIONG | Director | Aug 15 '26 | Option Exercise | 0.00 | 65,620 | 0 | 9,849,710 | Aug 18 |
| Hee Theng Fong | Director | Jul 20 '26 | Option Exercise | 0.00 | 31,640 | 0 | 31,640 | Jul 20 |
| Cao Lei | Director | Jun 28 '26 | Option Exercise | 0.00 | 60,760 | 0 | 130,800 | Jun 30 |
| Jin Hui | Chief Executive Officer | May 31 '26 | Option Exercise | 0.00 | 2,514,160 | 0 | 7,982,030 | Jun 02 |
| JI QI | Director | May 31 '26 | Option Exercise | 0.00 | 1,005,670 | 0 | 16,535,620 | Jun 01 |
| Zheng Jie | Director | May 15 '26 | Option Exercise | 0.00 | 307,850 | 0 | 373,090 | May 18 |
| Jin Hui | Chief Executive Officer | Mar 26 '26 | Option Exercise | 0.00 | 147,850 | 0 | 5,499,070 | Mar 27 |
| Hee Theng Fong | Director | Mar 20 '26 | Sale | 50.96 | 31,640 | 1,612,365 | 0 | Mar 23 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.